-
Artificial intelligence accurately diagnoses eye diseases and pneumonia
europeanpharmaceuticalreview
February 28, 2018
Using AI and machine learning techniques, researchers have developed a new computational tool to screen patients with common retinal diseases, potentially speeding diagnoses and treatment…
-
Engine Biosciences Raises $10M in Seed Financing to Accelerate Drug Discovery Using Genomics and Art
biospace
February 01, 2018
Engine Biosciences("Engine" today announced a $10 million round of seed funding.
-
Nuritas Raises €16 Million in Series A Funding Using Artificial Intelligence to Unlock Bioactive Pep
biospace
December 21, 2017
Nuritas announced today the closing of approximately $ 16 million Series A round of financing by Citigroup, a Chicago-based Cultivian Sandbox Ventures.
-
Speeding up drug discovery with Artificial Intelligence
biospectrumasia
September 07, 2017
Exscientia signed a 250 mn Euros deal with Sanofi in May.
-
Artificial intelligence predicts dementia before onset of symptoms
europeanpharmaceuticalreview
August 24, 2017
Scientists have used artificial intelligence capable of recognising the signatures of dementia two years before its onset…
-
GlaxoSmithKline taps Baltimore’s Insilico for AI-based drug discovery
fiercebiotech
August 17, 2017
GlaxoSmithKline has inked its second AI-based drug discovery deal of the summer. While the partners kept details under wraps, Insilico Medicine has its own drug discovery programs for age-related diseases, as well as cancer, diabetes and ALS.
-
Speeding up drug discovery process with Artificial Intelligence
biospectrumasia
August 11, 2017
Experts say, Artificial Intelligence saves half the time and money needed for discovery of new drugs
-
Artificial intelligence for human age-reversal
europeanpharmaceuticalreview
August 03, 2017
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing…
-
Artificial intelligence used for treatment of heart patients
biospectrumasia
June 15, 2017
The results can be used to enhance patient safety and to target the monitoring more accurately at the patients who would benefit the most from it.
-
Artificial intelligence to usher in new era of drug safety automation
europeanpharmaceuticalreview
June 14, 2017
Genpact’s new Pharmacovigilance Artificial Intelligence solution promises to transform drug safety data management and reporting…